BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 · Journal of Hepatology · 3,880 citations
https://doi.org/10.1016/j.jhep.2021.11.018
B
Bruno Sangro
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
810
Papers
48.5K
Citations
95
h-index
315
i10-index
Bruno Sangro is an academic researcher from Navarre Institute of Health Research. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Liver Disease Diagnosis and Treatment & Cancer Immunotherapy and Biomarkers. The author has an h-index of 95, co-authored 689 publications.
ORCID: 0000-0002-4177-6417Papers by this author
worksAssessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 · Journal of Clinical Oncology · 2,650 citations
https://doi.org/10.1200/jco.2014.57.9151
Advances in immunotherapy for hepatocellular carcinoma
2021 · Nature Reviews Gastroenterology & Hepatology · 1,299 citations
https://doi.org/10.1038/s41575-021-00438-0
Survival after Yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation
2011 · Hepatology · 648 citations
https://doi.org/10.1002/hep.24451
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 · Journal of Hepatology · 495 citations
https://doi.org/10.1016/j.jhep.2024.08.028
Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma
2020 · Journal of Hepatology · 402 citations
https://doi.org/10.1016/j.jhep.2020.07.026
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat